MetLife executive awarded stock; shares withheld

MetLife Inc. President, U.S. Business, Ramy Tadros reported stock-based compensation activity.

Rhea-AI Filing Summary

MetLife Inc. President, U.S. Business, Ramy Tadros reported stock-based compensation activity. He received 19,910 restricted stock units under a 2025 stock and incentive plan and 23,006 common shares from a 2023–2025 performance share award, deferring 80% of that payout. To cover taxes on the performance share payout, 2,299 shares were withheld at a price of $75.34 per share. After these awards and tax withholding, he directly owns 221,985 MetLife common shares.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider TADROS RAMY

Role President, U.S. Business

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	19,910	$0.00	$0.00
Grant/Award	Common Stock	23,006	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,299	$75.34	$173K

Holdings After Transaction: Common Stock — 221,985 shares (Direct)

Footnotes (3)

1. F1. Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.
2. F2. Shares acquired and earned from the determination of the performance factor for and payout of 2023-2025 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. The reporting person deferred 80% of these shares under the MetLife Leadership Deferred Compensation Plan, which allows eligible employees to defer receipt of such shares for a specific period of time.
3. F3. Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MetLife (MET) executive Ramy Tadros report in this Form 4?

Ramy Tadros reported stock-based awards and related tax withholding. He received restricted stock units and common shares from company incentive plans, and some shares were withheld to satisfy tax obligations, resulting in an updated direct ownership position in MetLife common stock.

How many MetLife shares did Ramy Tadros acquire in the latest Form 4?

Ramy Tadros acquired 42,916 MetLife common shares and units in total. This includes 19,910 restricted stock units and 23,006 common shares earned from a 2023–2025 performance share award under MetLife’s stock and incentive compensation plans.

Why were some MetLife (MET) shares disposed of in Ramy Tadros’s Form 4?

2,299 MetLife shares were withheld to cover tax obligations. These shares were retained by the company at $75.34 per share to satisfy Tadros’s tax withholding liability tied to the payout of his performance share award.

What MetLife stock incentive plans are referenced in Ramy Tadros’s Form 4?

The filing references MetLife’s 2025 and 2015 stock incentive plans. One award is a restricted stock unit grant under the 2025 Stock and Incentive Compensation Plan, and another is a performance share payout under the 2015 Stock and Incentive Compensation Plan.

How many MetLife shares does Ramy Tadros own after these transactions?

Ramy Tadros directly owns 221,985 MetLife common shares after the transactions. This figure reflects the addition of restricted stock and performance share payouts, net of 2,299 shares withheld to satisfy tax obligations associated with the performance award.

Did Ramy Tadros defer any MetLife shares from his performance award?

Yes, Ramy Tadros deferred 80% of the performance award shares. Under the MetLife Leadership Deferred Compensation Plan, he chose to defer receipt of most shares earned from the 2023–2025 performance share payout for a specified future period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:36 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TADROS RAMY

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NY 10166

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, U.S. Business

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		A		19,910	A	(1)	201,278	D
Common Stock	02/24/2026		A		23,006	A	(2)	224,284	D
Common Stock	02/24/2026		F(3)		2,299	D	$75.34	221,985	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.

2. Shares acquired and earned from the determination of the performance factor for and payout of 2023-2025 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. The reporting person deferred 80% of these shares under the MetLife Leadership Deferred Compensation Plan, which allows eligible employees to defer receipt of such shares for a specific period of time.

3. Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.